1. Home > Latest Topics >

Question 16: Cost-effectiveness benefits of the high-dose strategy

20 June, 2018

question_16_4


LATEST TOPICS

Managing Infectious Diseases in Emergency Medicine: A Specialist’s Approach
10 April, 2024
Advancing standardised diagnosis and treatment of acute infectious disease: Insights from an expert in theory–technique integration
08 April, 2024
Managing severe infections: Practical approaches for antibiotic use, including combination therapy
05 March, 2024
Updating Traditional Approaches: Expert Insights on Addressing Urinary Tract Infections
26 February, 2024
Antibiotic resistance may be driven by diverse factors, including extreme climatic events
14 February, 2024

RELATED ARTICLES

Managing Urinary Tract Infection: Treatment Strategies in Japan
20 July, 2022
Innovator versus Generic Antibiotics: Clinical Effectiveness in Pneumonia
23 October, 2023
Pharmacokinetic and microbial susceptibility studies of sitafloxacin
10 February, 2023
Community-acquired pneumonia: Updates in local treatment strategy and clinical experience with levofloxacin
07 October, 2021
New advancements in anti-infective therapy strategies for AECOPD
21 January, 2022